Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J.H. Schatz
NPM1-ALK Overexpression-Driven Toxicity in ALCL Is Partner Dependent and Driven by Phosphorylation of Novel Substrates Leading to Overstimulation of Biosynthetic Pathways
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
The ALK Inhibitor PF-06463922 Is Effective as a Single Agent in Neuroblastoma Driven by Expression of ALK and MYCN
DMM Disease Models and Mechanisms
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
Significance of Pathways Leading to RhoC Overexpression in Breast Cancer
Cisplatin-Induced Ototoxicity in Rats Is Driven by RIP3-Dependent Necroptosis
Cells
The Heterogeneous Landscape of ALK Negative ALCL
Oncotarget
Oncology
STAT3 Mutation Is Associated With STAT3 Activation in CD30+ ALK− ALCL
Cancers
Cancer Research
Oncology
Mouse Model of Poorly Differentiated Thyroid Carcinoma Driven by STRN-ALK Fusion
American Journal of Pathology
Forensic Medicine
Pathology
BCL6-Driven Lymphoma Is Dependent on LSD1 Corepression
Cancer Discovery
Oncology
Repotrectinib (TPX-0005), Effectively Reduces Growth of ALK Driven Neuroblastoma Cells
Scientific Reports
Multidisciplinary
Adolescents' Risk-Taking Behavior Is Driven by Tolerance to Ambiguity
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
